Biological age measured by DNA methylation clocks and reproductive history: Systematic review and meta-analysis.
Key claim: Earlier age at menopause and higher parity are cross-sectionally associated with greater epigenetic age acceleration on second-generation DNA methylation clocks (GrimAge, PhenoAge), while age at menarche shows no consistent association.
Abstract
Reproductive history has implications for long-term health, with menopausal timing and parity associated with chronic disease risk. DNA methylation (DNAm) clocks are biomarkers of aging and estimate epigenetic age acceleration (EAA) in reproductive tissues and systemically. DNAm clocks provide mechanistic insight into how reproductive history relates to aging. This study aimed to identify associations between reproductive history and DNAm clocks. Twenty-nine studies comprising 550,550 participants (median mean age=35.4 (IQR: 30.3-62.7) years, 100% female) assessing associations between reproductive history and EAA were included. Across studies, preterm birth and earlier age at menopause was consistently associated with higher EAA, yet age at menarche, pregnancy complications, and adverse birth outcomes showed mixed findings. Meta-analysis of cross-sectional studies showed each one-year earlier age at menopause was significantly associated with higher EAA, strongest in GrimAge (n = 5920, β=-0.08 years, 95% CI: -0.11, -0.05). No relationship was found between age at menarche and EAA in any DNAm clocks. Meta-analysis of parity showed associations with EAA using PhenoAge (n = 4508, β=0.13 years per delivery, 95% CI: 0.04, 0.21). These findings highlight that aspects of reproductive history are cross-sectionally associated with higher EAA, particularly measured with 2nd generation DNAm clocks (PhenoAge, GrimAge).
Why this matters
Second-generation methylation clocks are the field’s leading translational readout of biological age, and this meta-analysis shows they consistently register two female-specific reproductive exposures — earlier menopause and higher parity — while ignoring menarche timing. That pattern strengthens the argument that mid-life ovarian-hormone loss (not pubertal onset) is the reproductive event methylation clocks ‘see,’ aligning the menopause-driver hypothesis with an operational biomarker. Causality remains open: the associations are cross-sectional and could reflect shared upstream determinants of both reproductive trajectory and epigenetic aging.